MODEL-PREDICTED LYMPHOCYTE RESPONSE AND RECOVERY PROFILES FOR THE SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATORS OZANIMOD AND ETRASIMOD
Caroline A. Lee 1
Timothy Waterhouse 2
Michael Heathman 2
D. Alex Oh 2
Kiyomi Komori 2
John S. Grundy 2
1 Arena Pharmaceuticals, a wholly-owned subsidiary of Pfizer Inc, New York, San Diego, United States
2 Metrum Research Group, Tariffville, United States
Session
IBD (Posters)
Conference
UEG Week 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]